SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
23-May-24 4:10 PM View: | Kymera Therapeutics, Inc. (KYMR) | 23-May-24 | Sale | 2,575 | $34.99 | $90,104.70 | (6%) 46.76K to 44.18K | |
04-Mar-24 6:16 PM View: | Kymera Therapeutics, Inc. (KYMR) | 01-Mar-24 | Grant | 13,425 | -- | -- | 40% 33.33K to 46.76K | |
22-May-23 7:35 PM View: | Kymera Therapeutics, Inc. (KYMR) | 22-May-23 | Grant | 33,333 | -- | -- | 100% 0 to 33.33K | |
03-Mar-10 4:50 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 01-Mar-10 | Grant | 7,908 | -- | -- | 50% 15.85K to 23.76K | |
06-Jan-09 4:30 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 05-Jan-09 | Market Sale (Planned) | 4,573 | $6.20 | $28,375.00 | (22%) 20.43K to 15.85K | 40% |